Recent PHAT News
- Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting • GlobeNewswire Inc. • 05/01/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 11:05:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:05:06 AM
- Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/30/2026 10:59:00 AM
- Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 12:03:55 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 12:02:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 12:00:15 PM
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:03:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 10:11:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:06:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:05:13 PM
- Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance • GlobeNewswire Inc. • 02/26/2026 12:00:00 PM
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026 • GlobeNewswire Inc. • 02/17/2026 01:00:00 PM
- Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 09:38:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 09:42:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:45:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 09:03:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/08/2026 09:01:36 PM
- Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 01/08/2026 03:33:02 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/07/2026 09:34:34 PM
- Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 01/07/2026 09:05:00 PM
